Stay updated on rAAV2tYF-GRK1-RPGR in RPGR XLRP Clinical Trial
Sign up to get notified when there's something new on the rAAV2tYF-GRK1-RPGR in RPGR XLRP Clinical Trial page.

Latest updates to the rAAV2tYF-GRK1-RPGR in RPGR XLRP Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows a minor revision metadata update from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.3.4 appears with no substantive changes to study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedIntroduced a Locations section listing North Carolina, Ohio, Oregon, and Texas, and removed the previous state-location subsections and the HHS Vulnerability Disclosure entry. The revision tag was updated to v3.3.3.SummaryDifference0.6%

- Check91 days agoChange DetectedPublications section now notes that publications are automatically filled from PubMed and may not be about the study. The revision version was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check99 days agoChange DetectedThe funding/operating status notice was removed from the page, while the core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to rAAV2tYF-GRK1-RPGR in RPGR XLRP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the rAAV2tYF-GRK1-RPGR in RPGR XLRP Clinical Trial page.